Literature DB >> 8937972

Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.

L Zerva, S A Marshall, R N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8937972     DOI： 10.1093/jac/38.4.742

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.

Authors:  B A Odland; M E Erwin; R N Jones
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance.

Authors:  J L Watts; S A Salmon; M S Sanchez; R J Yancey
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactions.

Authors:  D Ince; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  Quinolone resistance due to reduced target enzyme expression.

Authors:  Dilek Ince; David C Hooper
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.